Marshalls makes concrete and stone paving for retail outlets and the construction industry, operating throughout the UK. Business has held up well despite the Brexit uncertainty.

Alec Cutler of Orbis Global Balanced Fund finds three stocks ripe with opportunity.

The group fell into administration this week, marking another setback for Sports Direct founder Mike Ashley. Matthew Partridge reports.

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK’s financial pages.

Antibiotic resistance could turn medical inconveniences into death sentences and become a bigger killer than cancer. Governments and pharmaceutical companies are fighting back. Sarah Moore reports.

Professional investor Andy Headley of Alliance Trust and Veritas Asset Management chooses three of his favourite stocks.

Saga, the company that offers products to the over-50s, has seen its shares hit a record low after a massive profit warning. So is it a bargain buy, asks John Stepek,or one to leave well alone?

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK’s financial pages.

Uncertainty over Brexit has prompted consumers and companies to put off investing in British stocks. Once clarity returns, cheap stocks should rebound, says David Stevenson.

Immunotherapy is a burgeoning sector that heralds a breakthrough against the world’s second-most deadly disease. Dr Mike Tubbs explains how investors can benefit too.

Alexion focuses on diseases that affect only a tiny proportion of the population – a lucrative niche.

Institutional investors keep their distance, but Katie Potts, manager of the Herald Investment Trust, is clearly doing something right.